Dr. Kenderian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- University of PennsylvaniaTranslational Research Program, Center for Cellular Immunotherapies, 2013 - 2016
- Penn MedicinePost-Doctoral Fellowship, Chimeric Antigen Receptor T cell Therapy, Translational Research Program (Carl H. June), 2013 - 2015
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2012 - 2013
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2010 - 2013
- McLaren Health Care/Flint/MSUChief Residency, Internal Medicine, 2008 - 2009
- McLaren Health Care/Flint/MSUResidency, Internal Medicine, 2006 - 2009
- University of Baghdad College of MedicineClass of 2003
Certifications & Licensure
- MN State Medical License 2010 - 2025
- PA State Medical License 2013 - 2014
- MI State Medical License 2006 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Innovation Award – Research Department of Medicine, Mayo Clinic, 2016
- Career Development Award Department of Medicine, Mayo Clinic, 2015-2016
- Best Abstract Award American Society for Blood and Marrow Transplantation, 2015-2016
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAllogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic Experience.Sachi Singhal, Salwa S Saadeh, Urshila Durani, Ankit Kansagra, Hassan B Alkhateeb, Mithun V Shah, Abhishek Mangaonkar, Saad Kenderian, Shahrukh Hashmi, Mrinal V Patnai...> ;Transplantation and Cellular Therapy. 2023 Mar 1
- 2 citationsPre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.Aldo A Acosta-Medina, Isla McKerrow Johnson, Radhika Bansal, Matthew Hathcock, Saad J Kenderian, Urshila Durani, Arushi Khurana, Yucai Wang, Jonas Paludo, Jose C Villa...> ;Blood Cancer Journal. 2023 Jan 5
- 4 citationsAcute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).Jacqui-Lyn Saw, M Hasib Sidiqi, Michael Ruff, Sara Hocker, Hassan Alkhateeb, Stephen M Ansell, N Nora Bennani, David Dingli, Suzanne R Hayman, Patrick B Johnston, Pras...> ;Blood Cancer Journal. 2022 Apr 13
- Join now to see all
Journal Articles
- Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapiesRuella M, Barrett DM, Kenderian SS, Shestova O, Hofmann TJ, Perazzelli J, Klichinsky M, Aikawa V, Nazimuddin F, Kozlowski M, Scholler J, Lacey SF, Melenhorst JJ, Morri..., J Clin Invest, 1/29/2016
- Activity of anti-CD19 Chimeric Antigen Receptor T cells in Combination with Ibrutinib in Mouse Xenografts of Mantle Cell LymphomaRuella M, Kenderian SS, Shestove O, Fraietta J, Qayyum S, Zhang Q, Maus MV, Liu X, Nunez-Cruz S, Klichinsky M, Kawalekar O, Milone M, Lacey S, Mato A, Schuster S, Kalo..., Clin Cancer Res, 1/27/2016
- The microbiome and immune regulation after transplantationTabibian JH, Kenderian SS, Transplantation, 1/11/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Improved Anti-Tumor Response of Chimeric Antigen Receptor T Cell (CART) Therapy after GM-CSF Inhibition is Mechanistically Supported By a Novel Direct Interaction of G...Saad S. Kenderian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (C...Saad S. Kenderian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Targeting of CD19 By Tafasitamab Does Not Impair CD19 Directed Chimeric Antigen Receptor T Cell Activity in VitroSaad S. Kenderian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Preclinical Modeling of CART Cells and Combination ImmunotherapySan Francisco, CA - 1/1/2017
- CART cell therapy in the context of stem cell transplantationMinneapolis, MN - 1/1/2016
- Checkpoint inhibitors in hematology and Bone Marrow TransplantationMinneapolis, MN - 1/1/2016
- Join now to see all
Press Mentions
- Addressing the Challenges of Chimeric Antigen Receptor-T Cell TherapyAugust 2nd, 2022
- The Team That Kept Translational Science on the Fast Track to Curb COVID-19 PneumoniaJune 22nd, 2021
- Cancer to COVID-19June 22nd, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: